It wasn’t until my late 30s that I realized something needed to change. I was lethargic and barely had the energy to play ...
Welcome to Wrinkles Week on the Strategist, where we’re deeply vetting skin-care solutions for anyone looking to smooth fine ...
Final results from the pivotal CheckMate 238 trial showed adjuvant nivolumab continues to significantly improve RFS compared with ipilimumab for patients with advanced melanoma, according to data ...
Safety results showed no increase in immune-mediated adverse events (34.0% vs 38.4%) or treatment-related adverse events ...
Sunday delivered a few close games involving teams toward the top of the 2026 NFL Draft order, but only one team with one win or fewer emerged victorious. In a battle between one-win teams Cleveland ...